Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03106233|
Recruitment Status : Completed
First Posted : April 10, 2017
Last Update Posted : April 10, 2017
|Condition or disease||Intervention/treatment|
|Breast Cancer||Procedure: LTP flap|
|Study Type :||Observational|
|Actual Enrollment :||86 participants|
|Official Title:||The Lateral Thigh Perforator (LTP) Flap for Autologous Breast Reconstruction: A Prospective Analysis of 138 Flaps|
|Actual Study Start Date :||September 2012|
|Actual Primary Completion Date :||November 2016|
|Actual Study Completion Date :||December 2016|
LTP flap breast reconstruction
All consecutive patients who underwent LTP flap breast reconstructions (unilateral, bilateral or stacked unilateral) between September 2012 and November 2016 at three centers in Maastricht, the Netherlands, and New York and New Orleans, the United States, were included. Autologous breast reconstruction was performed by using the upper lateral thigh region as a donor site.
Procedure: LTP flap
A flap is harvested from the upper lateral thigh region based on septocutaneous perforators located in the posterior septum between the tensor fascia latae and gluteus medius muscles.
- Recipient- and donor-site complications [ Time Frame: Through study completion up to an average of 12 months post-operatively ]Recipient site: Total flap loss, partial flap loss, venous congestion, infection, hematoma, seroma, fat necrosis and wound complications. Donor site: Infection, hematoma, seroma, fat necrosis, wound complications.
- Flap re-explorations [ Time Frame: Through study completion up to an average of 12 months post-operatively ]Total number of flaps that required a re-exploration because of arterial or venous insufficiency, hematoma or kinking of the pedicle.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03106233
|Maastricht University Medical Center|
|Maastricht, Limburg, Netherlands, 6229 HX|
|Principal Investigator:||Stefania Tuinder, MD, PhD||Maastricht University Medical Center|